This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
coronavirus: Archive
Biotech Bonanza: COVID Launches Science at Warp Speed
by Kevin Cook
From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.
MRNAPositive Net Change VIVONegative Net Change NVAXPositive Net Change AXSMPositive Net Change AVXLNegative Net Change VXRTPositive Net Change
biotechs coronavirus pharmaceuticals
Bear of the Day: Illumina (ILMN)
by Kevin Cook
Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs
ILMNNegative Net Change EDITPositive Net Change NVTAPositive Net Change ARKKPositive Net Change ARKGNegative Net Change
biotechs coronavirus genetics genomics
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations
VIVONegative Net Change QDELNegative Net Change EDITPositive Net Change CRSPNegative Net Change
coronavirus genetics genomics medical
With Vaccine Distribution, What Stocks Do I Buy?
by John Blank
A Forward Looking Market Can Be Beguiling.
GSNegative Net Change SCHWPositive Net Change QDELNegative Net Change
biotechs coronavirus
Moderna Vaccine: The Power of mRNA Technology
by Kevin Cook
Warp speed was just the ticket to launch top COVID-19 vaccines -- and a revolution in medicine
AZNNegative Net Change PFENegative Net Change MRNAPositive Net Change IBBPositive Net Change XBIPositive Net Change
biotechs coronavirus
Bull of the Day: Quidel (QDEL)
by Kevin Cook
COVID and influenza A+B tests have launched sales and profit estimates triple-digits into 2021
QDELNegative Net Change PFENegative Net Change MRNAPositive Net Change
biotechs coronavirus medical
Bear Of The Day: Royal Caribbean Cruises (RCL)
by Daniel Laboe
It is time to consider pulling profits from this frothy cruise line stock
CCLNegative Net Change RCLNegative Net Change
coronavirus travel-leisure
Stocks: Overvalued or Cheap Heading Into 2021?
by Tracey Ryniec
S&P 500 earnings are expected to rise 21% in 2021 and that may be too conservative as the coronavirus vaccine rolls out.
INTCPositive Net Change AAPLPositive Net Change SEPositive Net Change SLYPositive Net Change DOCUNegative Net Change
coronavirus stock-performance
IPO Week For DASH & ABNB
by Daniel Laboe
Christmas is coming early for two well-timed IPO's from digitally driven market leaders Airbnb and DoorDash
TSLAPositive Net Change
coronavirus e-commerce internet-content tech-stocks travel-leisure
Bull of the Day: PulteGroup, Inc. (PHM)
by Benjamin Rains
PulteGroup has posted three-straight quarters of solid top-line growth in 2020 and it stands to benefit from the stellar housing market that could be poised to keep growing...
PHMNegative Net Change LENNegative Net Change
construction coronavirus